Tredje Ap Fonden Biogen Inc. Transaction History

Tredje Ap Fonden

$10.8 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$222.59 - $267.94 $8.26 Million - $9.95 Million	-37,120 Reduced 73.68%	13,263 $3.43 Million
Q1 2023 May 10, 2023	BUY	$256.56 - $292.34 $10.6 Million - $12.1 Million	41,286 Added 453.84%	50,383 $14 Million
Q4 2022 Feb 10, 2023	BUY	$252.44 - $306.72 $176,708 - $214,704	700 Added 8.34%	9,097 $2.52 Million
Q3 2022 Nov 10, 2022	SELL	$194.69 - $268.46 $4.02 Million - $5.55 Million	-20,667 Reduced 71.11%	8,397 $2.24 Million
Q4 2021 Feb 10, 2022	BUY	$223.92 - $287.77 $6.17 Million - $7.93 Million	27,564 Added 1837.6%	29,064 $6.97 Million
Q2 2021 Aug 06, 2021	SELL	$259.0 - $414.71 $4.86 Million - $7.79 Million	-18,778 Reduced 92.6%	1,500 $519,000
Q2 2020 Aug 11, 2020	SELL	$258.66 - $342.55 $2.63 Million - $3.48 Million	-10,165 Reduced 33.39%	20,278 $5.43 Million
Q1 2020 May 11, 2020	SELL	$268.85 - $341.04 $760,576 - $964,802	-2,829 Reduced 8.5%	30,443 $10.1 Million
Q4 2019 Feb 10, 2020	SELL	$220.06 - $304.07 $769,769 - $1.06 Million	-3,498 Reduced 9.51%	33,272 $9.87 Million
Q3 2019 Nov 12, 2019	SELL	$217.44 - $243.88 $533,380 - $598,237	-2,453 Reduced 6.25%	36,770 $8.56 Million
Q2 2019 Aug 09, 2019	BUY	$219.29 - $241.72 $1.34 Million - $1.47 Million	6,100 Added 18.42%	39,223 $9.17 Million
Q1 2019 May 10, 2019	BUY	$216.71 - $338.96 $381,626 - $596,908	1,761 Added 5.62%	33,123 $7.83 Million
Q4 2018 Feb 11, 2019	SELL	$278.5 - $352.75 $4.49 Million - $5.68 Million	-16,106 Reduced 33.93%	31,362 $9.44 Million
Q3 2018 Nov 13, 2018	SELL	$293.51 - $383.83 $2.63 Million - $3.43 Million	-8,947 Reduced 15.86%	47,468 $16.8 Million
Q2 2018 Aug 09, 2018	BUY	$257.52 - $306.91 $2.4 Million - $2.86 Million	9,321 Added 19.79%	56,415 $16.4 Million
Q1 2018 May 09, 2018	BUY	$260.13 - $367.91 $114,197 - $161,512	439 Added 0.94%	47,094 $12.9 Million
Q4 2017 Feb 12, 2018	BUY	$307.64 - $344.58 $36,916 - $41,349	120 Added 0.26%	46,655 $14.9 Million
Q3 2017 Nov 13, 2017	BUY	$281.15 - $329.69 $13.1 Million - $15.3 Million	46,535	46,535 $14.6 Million

Others Institutions Holding BIIB

# of Institutions

1,032

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tredje Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Tredje Ap Fonden with notifications on news.

Account